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A B S T R A C T
Cardiovascular causes have been estimated to be responsible for more than two thirds of the considerable
mortality attributed to air pollution. There is now a substantial body of research demonstrating that exposure to
air pollution has many detrimental effects throughout the cardiovascular system. Multiple biological mechan-
isms are responsible, however, oxidative stress is a prominent observation at many levels of the cardiovascular
impairment induced by pollutant exposure. This review provides an overview of the evidence that oxidative
stress is a key pathway for the different cardiovascular actions of air pollution.
1. Introduction
Air pollution has far-reaching consequences on biodiversity, and its
impact on human health has moved this issue to the top ranks of the
political agenda at an international level. Air pollution is the number
one environmental risk factor for mortality and the fifth greatest risk
factor for all-cause mortality, overall [1]. Recently, it has been revealed
that air pollution has effects throughout the body [2,3], however, its
effects on the cardiovascular system, in particular, carry a dispropor-
tionate burden both in terms of morbidity and mortality. Indeed, due to
high prevalence of cardiovascular disease globally and the intrinsic
fatality of many cardiovascular conditions, more than two thirds of the
mortality attributed to air pollution arise from cardiovascular causes, in
particular ischaemic heart disease and cerebrovascular disease [1,4].
Additionally, cardiovascular complications are likely to play important
contributing roles to the action of air pollution in the progression of
diseases in other organs [5,6].
Great progress has been made in establishing the mechanisms un-
derlying the cardiovascular effects of air pollution. It has become clear
that oxidative stress plays a key role in the cardiovascular effects of
many air pollutants. This topic was reviewed in detail in 2012 [7], with
the 2010–2016 data expertly reviewed in Kelly & Fussell 2017 [8]. This
review is an amalgamation of previous evidence, together with more
recent data (January 2016 to October 2019). By structuring the evi-
dence into different facets of the cardiovascular pathophysiology, the
intention is that this review will provide a comprehensive overview of
role of oxidative stress in the cardiovascular effects of air pollution.
2. Air pollution
Air pollution includes a vast range of substances derived from many
different sources and chemical reactions within the atmosphere. A brief
overview is given here, and readers are referred to accompanying pa-
pers in this special issue for further details. Airborne pollutants can
arise from both natural sources (e.g. forest fires, volcanic eruptions,
aerosolised soil and dusts, pollen and moulds) and anthropogenic
sources (e.g. industry, power plants, traffic, household heating,
cooking, construction, mechanical wear, agriculture, etc.). ‘Ambient’ air
pollution refers to outdoor air pollution, and has received the greatest
attention historically, although indoor sources of air pollution are
gaining traction, especially in terms of the burden of disease in devel-
oping nations. The bulk of research into ambient air pollution tends to
centre on urban air pollution due to, among other reasons, the high
density of urban populations, greater levels of traffic-derived emissions
and increasing urbanisation of societies worldwide.
Urban pollution is a complex cocktail of chemicals. Gases such as
sulphur dioxide (SO2), carbon dioxide (CO2), carbon monoxide (CO),
ozone (O3) and nitrogen dioxide (NO2) are present in varying amounts.
Gaseous pollutants have the potential to cause short- and long-term
health effects, possibly in an additive manner to particulates [9]. Many
of these gases have oxidative properties, and induction of oxidative
stress (together with inflammation) is a likely mechanism by which
they can affect human health [10]. Semi-volatile species such as ben-
zene, naphthalene, formaldehyde, polyaromatic hydrocarbons (PAHs)
exist as liquid droplets, but can also transition between gaseous and
particulate phases of air pollution [11]. Additionally, there are nu-
merous sources of minute airborne particulate matter (PM). PM is ca-
tegorised according to particle size. Coarse particles (PM10) are parti-
cles with a diameter of 10 μm or less, fine particles (PM2.5) have a
diameter of 2.5 μm or less, and ultrafine particles (or “nanoparticles”)
have a diameter of 100 nm or less (although precise definitions of these
categories can be distinct in different disciplines). PM is monitored and
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regulated in the environment through stationary monitoring networks
that measure PM10 and (slightly less frequently) PM2.5. It is not prac-
tically possible to widely measure ultrafine PM using monitoring net-
works in the environment at present. Elemental and organic carbon
form a significant part of urban PM (especially that derived from
combustion) but non-carbon constituents such as various mineral dusts,
sea salt, ammonium, nitrates, sulfates, and others, are also present [12].
The composition of particles is one of the key physiochemical properties
Abbreviations
AHA American Heart Association
AhR aryl hydrocarbon receptors
BBB blood brain barrier
BC black carbon
CAPs concentrated ambient particles
CIMT carotid intima media thickness
CO carbon monoxide
CO2 carbon dioxide
DE diesel exhaust
DEP diesel exhaust particulate
ECG electrocardiogram
ET-1 endothelin-1
HDL high density lipoprotein
HRV heart rate variability
ICAM-1 intercellular adhesion molecule-1
LDL low density lipoprotein
LOX-1 lectin-like oxidized low density lipoprotein receptor
NAC N-acetylcysteine
NADPH oxidase nicotinamide adenine dinucleotide phosphate oxi-
dase
NMDA N-methyl-D-aspartate
NO nitric oxide
NO2 nitrogen dioxide
NOS nitric oxide synthase
O3 ozone
8-OH-dG 8-oxo-2′-deoxyguanosine
oxLDL oxidized low density lipoprotein
PAHs poly-aromatic hydrocarbons
PM particulate matter
PM10 particulate matter with a diameter <10 μm
PM2.5 particulate matter with a diameter <2.5 μm
SO2 sulphur dioxide
SOD superoxide dismutase
VCAM-1 vascular cell adhesion molecule-1
vWF von Willebrand factor
Fig. 1. Association between fine particulate matter (PM2.5) and: a) risk of mortality and b) carotid atherosclerosis. a) Letters represent first letter of city marked on
map of USA. Dotted line is approximate correlation added as indicator of the linearity of the relationship. Data from Dockery et al. 1993 [27]; b) Map shows modelled
PM2.5 air pollution in area surrounding Los Angeles. CIMT = carotid intima media thickness. Data from Kunzli et al. 2005 [30].
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determining the biological response to inhaled PM. Organic carbon
species (PAHs, nitro-PAHs, alkanes, alkenes, alkyl-benzenes, quinones,
etc.) and redox-active transition metals are frequently implicated in the
health effects of urban PM, and the availability of these chemicals on
the surface of PM influences the biological response to these particles
[13–18].
Particle size is also an important factor for the health effects of PM.
Size is a determinant of the degree of penetration into the lung and
ability (or inability) of biological clearance mechanisms to remove in-
haled PM [19,20]. Importantly, the size also has an immediate effect on
the relative surface area of the PM, with small particles having a sig-
nificantly greater surface area than the equivalent mass of a larger
particle of the same material (although this is complicated somewhat by
particle agglomeration in the air and in biological fluids). Accordingly,
health associations are often greater and/or more consistent for PM2.5
than PM10 [9,21]. There is a general assumption that ultrafine particles
could pose a greater risk to health due to their larger relative reactive
surface area, and their ability to penetrate deep into the alveoli of the
lungs and into the bloodstream [22,23]. Vehicle exhaust is a prominent
sources of ultrafine particles in urban PM, and diesel exhaust (DE) is of
particular interest due to the greater proportion of ultrafine PM com-
pared with gasoline/petrol engine emissions, as well as the tendency to
be associated with high levels of co-pollutants such as NO2 [24,25].
Many of the above pollutants and their constituents have some ca-
pacity to induce health effects. However, in relation to the cardiovas-
cular system, epidemiological associations tend to be more consistent
for the particulate components [9,26]. For this reason, this review will
largely focus on the cardiovascular actions of PM and especially that of
vehicle-derived emissions as prominent sources of ultrafine PM.
3. Air pollution and cardiovascular disease: overview of
epidemiological evidence
The cardiovascular effects of air pollution came to prominence in
the early 1990s. In 1993, Dockery and colleagues examined the re-
lationship between PM2.5 and hospital admissions/deaths from cardi-
ovascular disease in six North American cities with broadly similar
demographics [27]. They found a strikingly linear relationship between
levels of PM2.5 and cardiovascular morbidity and mortality (Fig. 1a). An
adjusted mortality-rate ratio of 1.37 (95%CI: 1.11–1.68) was found for
cardiopulmonary mortality between the least (11 μg/m3 PM2.5) and
most (30 μg/m3 PM2.5) polluted cities. A later study by the group [28]
expanded this data to include 51 metropolitan areas throughout the
USA. It was estimated that a decrease of 10 μg/m3 PM2.5 would increase
average life expectancy by approximately 7 months. Furthermore, a
2007 study of more than 65,000 women in the USA demonstrated a
24% increase in risk of a cardiovascular event and an alarming 76%
increase in the risk of death from cardiovascular disease [29]. Lastly, a
seminal study by Kunzli et al. [30] showed a relationship between ex-
posure to PM2.5 across Los Angeles, USA, and atherosclerosis (a chronic
disease of the vasculature that underlies coronary artery disease and
many other cardiovascular conditions). A difference of 10 μg/m3 PM2.5
was associated with a 4–6% increase in carotid-intima thickness
(CIMT); a measure of atherosclerosis in the arteries of the neck that is
predictive of disease in other vascular beds (Fig. 1b).
Air pollution is associated with mortality and cardiovascular events
(e.g. a heart attack or a stroke) in both the long- and short-term.
Utilising data from three large US cohorts (359–500 thousand partici-
pants), Pope et al. demonstrated that long-term exposure to air pollu-
tion (1–4 years) was associated with an 8–18% increase in cardiovas-
cular mortality per 30 μg/m3 PM2.5 [31]. An 8 year follow-up of ~5000
individuals found almost a doubling of the risk of cardiovascular mor-
tality in individuals living in close proximity to a major road [32]. In
the short-term, increases in cardiovascular mortality [33,34] and cor-
onary events [35] have been associated with ambient PM on the same
and preceding day. The coronary effects of traffic-derived pollution
may occur even earlier, as individuals presenting with myocardial in-
farction were more likely to have been in traffic 1–2 h beforehand
[36–38].
The dose-response relationship between PM and cardiovascular
mortality still requires investigation, especially at low and high doses.
Current evidence suggests that there is a linear relationship between
moderate levels of PM and mortality, followed by a plateau in mortality
rates at higher levels (“supralinear”) [39–41]. Importantly, relatively
low levels of air pollution can promote cardiovascular disease long-term
[40]. Notably, these associations hold true for levels of PM2.5 that are
currently below international guidelines (e.g. World Health Organisa-
tion; annual PM2.5< 10 μg/m3) [42,43].
The volume of epidemiological evidence stretches far beyond mor-
tality and broad metrics of morbidity. Indeed, air pollution has been
shown to be associated with most cardiovascular conditions, including
coronary artery disease [29,44,45], cardiac arrhythmia and arrest
[35,46,47], acute myocardial infarction [45,48,49], heart failure
[48,50–52], cerebrovascular disease [29,53–57], peripheral arterial
disease [58,59] and venous thromboembolism [60,61]. Comprehensive
reviews of the mechanistic evidence for these associations have con-
cluded that there is a strong case for causality between air pollution and
a wide range of cardiovascular endpoints [62]. This conclusion is
concisely summarised in the seminal American Heart Associations
(AHA) systematic reviews in 2004 and 2010 [9,63]: “evidence is con-
sistent with a causal relationship between PM2.5 exposure and cardio-
vascular morbidity and mortality” [9]. The weight of evidence has only
been bolstered in the prevailing years. A 2015 expert position paper
[64] concluded that “There is now abundant evidence that air pollution
contributes to the risk of cardiovascular disease and associated mor-
tality, underpinned by credible evidence of multiple mechanisms that
may drive this association”, stressing that “Air pollution should be
viewed as one of several major modifiable risk factors in the prevention
and management of cardiovascular disease”.
4. Oxidative stress in the cardiovascular effects of air pollution
Oxidative stress has been cemented as a key pathway underlying the
cardiovascular effects of air pollution [7,65,66]. Both epidemiological
studies and controlled exposure studies in human subjects have pro-
vided strong evidence for oxidative pathways and these foundations
have been built upon by a network of mechanistic studies in animals
and cellular models (expertly summarised in Ref. [8]). The 2010 AHA
statement concluded that “At a molecular level, oxidative stress as a
critically important cause and consequence of PM-mediated cardio-
vascular effects has a sound experimental basis” [9]. This review aims
to be a comprehensive review of the role of oxidative stress in the
cardiovascular effects of air pollution (for further information on the
wider effects of PM-induced oxidative stress see Refs. [66–68]). Studies
have been identified that contain both an association between air pol-
lution and cardiovascular function, and mechanistic evidence for oxi-
dative stress (e.g. assessment of the oxidative potential of a pollutant,
measurement of a biomarker of oxidative stress, identification of a
source of free radicals, exploration of genetic polymorphisms conferring
altered susceptibility to oxidative stress, or prevention/reversal with
antioxidant compounds). The sheer volume of literature on this topic
prohibits detailed critical analysis of individual assays, study designs
and inconsistences. Nonetheless, all evidence in this overview is derived
from peer-reviewed journals and expert book chapters. Furthermore, by
structuring the review by different facets of cardiovascular system, it is
clear that oxidative stress is a common, and important, mechanism in
many of the different processes linking air pollution to cardiovascular
mortality.
4.1. Vascular tone/endothelial dysfunction
The tone of blood vessels is crucial to the distribution of blood
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around the body, and plays a key role in both the maintenance of
homeostasis and the response to stimuli. Endothelial cells are the thin
layer of cells that line the inner surface of blood vessels. The en-
dothelium acts as an interface between the blood and vascular wall,
both physically and through the synthesis and release of a range of
active mediators. Endothelial dysfunction plays a key early role in
vascular impairment and disease. Subsequently, the excessive con-
tractility and loss of vasodilator responses caused by endothelial dys-
function are hallmarks of chronic cardiovascular disease.
Epidemiology. In 2005 O'Neill et al. demonstrated that PM2.5 ex-
posure was associated with a decreased in vasodilator response in the
brachial artery of diabetic individuals [69]. Subsequent evidence im-
plicated oxidative stress as a potential mechanism. The reduction in
brachial artery diameter to PM2.5 and black carbon (BC; used as an
indicator for combustion-derived PM) in elderly individuals was asso-
ciated with increased in plasma endothelin-1 (ET-1; a potent vasocon-
strictor molecule) and oxidative stress (thiobarbituric reactive sub-
stances) [70]. Similar observations were made for the reduction in
microvascular function in middle-aged and elderly individuals, that
demonstrated that smaller arteries (which play a substantial role in
blood pressure regulation, with high blood pressure ("hypertension")
being a prominent risk factor of cardiovascular disease) were also
narrowed by PM [71]. Accordingly, PM exposure has been regularly
associated with small, but significant, elevations in blood pressure
[72–77]. The hypertensive effect of air pollution is likely to be multi-
factorial in terms of both the contributing biological mechanisms and
different air pollutants [72]. A role for oxidative stress has been pos-
tulated by the nature of the pattern of vascular impairment induced by
PM (Fig. 2). The oxygen free radical superoxide scavenges nitric oxide
(NO), a key endothelial-cell derived mediator that controls vasodila-
tation of blood vessels. PM2.5 exposure was associated with impairment
of both flow-mediated dilatation (endothelium-dependent) and vaso-
dilation to nitroglycerin (an endothelium-independent NO-releasing
vasodilator). This pattern of impairment (inhibition of vasodilators
acting through NO) is suggestive of oxidative stress [69]. A role for both
oxidative stress and inflammation is supported by observations that the
attenuation of flow-mediated dilatation in response to PM2.5 was
greater in individuals with glutathione-S-transferase M1
polymorphisms, and associated with increases in myeloperoxidase [78].
Similarly, healthy volunteers taken on a 1.5-h drive along a busy
roadway showed diminished reactive hyperemia responses (a measure
of endothelial-mediated vasodilatation) and reduced levels of plasma
nitrite (a surrogate for endothelial NO) [79]. This effect was not ap-
parent when cabin filters were used to lower particulate levels in the
vehicle.
Various blood and urine markers of oxidative stress are upregulated
in participants with greater levels of PM exposure (e.g. Refs. [80–92]).
Additionally, personal monitoring of pollutants has been used to show
that cumulative indoor and outdoor exposure to ultrafine particles is
associated with oxidation of DNA in the blood [93]. Traffic-related
pollutants, specifically, appear to closely linked to circulating bio-
markers of oxidative stress [87,89]. Exposure to PM decreased en-
dothelial-mediated dilatation in the microvasculature of elderly in-
dividuals in Los Angeles, USA [94]. The degree of impairment was
greatest for PM with characteristics of traffic-derived PM (black carbon
and NO2) and was correlated with the oxidative potential of the PM in
vitro.
There is evidence that polymorphisms in antioxidant enzymes lead
to a greater hypertensive response to pollutant exposure in comparison
to those with the standard genetic alleles [95]. In contrast, other studies
have not found the associations between PM and vascular function/
blood pressure to be accompanied by oxidative stress biomarkers
[96,97] or genetic status of antioxidant enzymes [98].
There is a growing body of evidence linking air pollution to meta-
bolic syndrome and diabetes; diseases that are frequently associated
with cardiovascular complications, including microvascular dysfunc-
tion [99,100]. While the associations between air pollution and dia-
betes are not discussed in detail in the current review, it is worthwhile
noting that increases in both insulin resistance and biomarkers of oxi-
dative stress were associated with air pollution exposure in children
[101]. Finally, ultrafine particles altered levels of endothelial pro-
genitor cells (that are likely to be involved in the repair of endothelial
damage) and leukocyte free radical production in non-smokers in Co-
penhagen [102].
Controlled Exposure Studies. Controlled exposure studies in
healthy volunteers have been vital in exploring the biological
Fig. 2. Exposure to PM inhibits vasodilatation
mediated through endothelial and nitric-oxide
pathways. A combination of different stimuli and
drug infusions can be used to explore the mechan-
isms by which vasodilatation is impaired (see ex-
ample scenarios). Flow-mediated dilatation (FMD)
and infusion of drugs such as acetylcholine (ACh)
and bradykinin (BK) stimulate endothelial cells to
synthesise nitric oxide (NO). NO diffuses to the
smooth muscle to activate guanylate cyclase (GC)
which ultimately induces relaxation of the vascular
smooth muscle and dilatation of the blood vessel.
Drugs such as nitroglycerin (NTG or glyceryl trini-
trate) and sodium nitroprusside (SNP) act in-
dependently of the endothelium to generate NO
from their molecular structure. Drugs such as ver-
apamil (and isoprenaline in rodent models) activate
receptors on vascular smooth muscle cells to induce
vasodilatation independently of NO. Exposure to
PM tends to inhibit pathways involving NO, but not
NO-independent pathways. This pattern suggests
that oxidative stress is a prominent mechanism of
action, due to the scavenging of NO by superoxide
free radicals (O2-.). Other abbreviations:
AC = adenylate cyclase, Ca2+L , L-type calcium
channel NOS = nitric oxide synthase.
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mechanisms of specific pollutants without many of the confounding
variables of epidemiological studies. Controlled exposures to dilute
diesel exhaust (DE) induced a compensatory increase in levels of anti-
oxidants to the lung lining fluid as a response to the oxidative insult to
the lungs [103,104], setting the scene for use of this approach to study
the cardiovascular effects of pollutants. A 2-h inhalation of con-
centrated ambient particles (CAPs; ~150 μg PM/m3) and ozone
(120 ppb) from the city of Toronto induced vasoconstriction of brachial
arteries [105]. A potential involvement of a systemic oxidative response
was suggested by the greater levels of oxidation of the DNA of blood
monocyte following controlled exposure to roadside ultrafine PM
[106]. A program of work by led by Newby and Mills utilised controlled
exposures to identify the mechanisms by which exposure to DE im-
paired cardiovascular function. Their first study demonstrated that a 1-
h exposure of DE (~300 μg PM/m3) caused a potent attenuation of
vasodilator responses in the forearm [107]. By utilising a series of
different vasodilator infusions, they demonstrated that DE caused in-
hibition of endothelium-dependent vasodilatation (to acetycholine,
bradykinin) and endothelium-independent NO donor drugs (to sodium
nitroprusside), but not vasodilators that act independently of the NO
pathway (verapamil) (see Fig. 2). This pattern of inhibition strongly
supports a role for oxidative stress, as opposed to another means of
vascular dysfunction such as non-specific damage to endothelial cells or
de-regulation of vascular smooth muscle contractility (although other
mechanisms such as down-regulation of the NO target enzyme, gua-
nylate cyclase, could also be involved). This profile of vascular im-
pairment was consistently observed in subsequent studies by these re-
searchers [108–110]. Inhalation of DE altered both antioxidant genes
and genes regulating vascular homeostasis (e.g. vascular endothelial
growth factor) in peripheral blood monocytes [111]. Loss of endothelial
NO-signalling contributed to the increased sensitivity to circulating ET-
1 following acute exposure to DE [112]. Controlled exposure to DE also
impaired skin microvascular responses to endothelium-dependent va-
sodilators, but not an exogenous NO donor drug [113]. Although the
response to the NO donor drug was not altered, blood serum from vo-
lunteers induced the release of superoxide in cultured endothelial cells,
the extent of which was related to the total dose of the volunteer re-
ceived.
Supplementation with antioxidant-rich fish oils have been found to
limit the extent of endothelial dysfunction in response to controlled
exposure to CAPs [114]. Conversely, another study found that N-acet-
ylcysteine (NAC), a compound with antioxidant properties (albeit it can
also affect cell signalling through means unrelated for oxidative stress),
promoted vasoconstriction to DE rather than prevented it [115]. The
reasons for this unexpected finding were not immediately apparent
although could involve changes in vasoconstrictive eicosanoids or al-
terations in expression of basal antioxidants. The particulate compo-
nents seem to drive the acute vascular effects of DE [110,116], and not
gases such as NO2 [117] or O3 [118]. In this regard, a recent study
found that controlled exposure to higher concentrations of ozone in-
creased blood levels ET-1, but actually decreased blood levels of ni-
trotyrosine (a marker of the reaction product of NO and superoxide)
[119].
Animal models. Rodent models have been beneficial in exploring
the mechanisms underlying the increased vasoconstriction/impaired
vasodilation. The mechanistic evidence gathered by these studies pro-
vides strong evidence that oxidative stress may play a significant con-
tributing role in mediating the impairments [7,120]. Inhalation of DE in
rats led to impaired endothelium-dependent relaxation in coronary
arteries, an effect that could be reversed with superoxide scavengers
[121]. Two weeks exposure of rats to PM2.5 (albeit at high concentra-
tions of 600 μg/m3) impaired pulmonary artery vasodilator function
and decreased eNOS expression, in line with a compensatory increase in
vascular superoxide dismutase (SOD; an enzyme which converts su-
peroxide into oxygen and hydrogen peroxide) [122]. Interestingly, ni-
tric oxide synthase (NOS; the enzymatic source of NO) inhibitors, or
additional of NOS co-factors, prevented the impairment, suggesting that
NOS uncoupling (causing generation of superoxide from NOS instead of
NO) was an important mechanism. In support of this, sub-chronic ex-
posure to PM2.5 led to depletion of the co-factors needed for the NO-
generation from endothelial NOS [123]. Other cellular sources of oxi-
dative stress have been implicated. A role for nicotinamide adenine
dinucleotide phosphate oxidase (NADPH oxidase) has been implicated
in vascular impairment and elevated blood pressure induced by PM2.5
[123–125] and diesel exhaust particulate (DEP) [126,127]. Exposure of
rats to residual oil-fly ash caused rapid attenuation of relaxation re-
sponses in the microvasculature and adherence of myeloperoxidase-
containing leukocytes to the vessel wall, suggesting that leukocytes
enzymatically contributed to free radicals linked to the endothelial
dysfunction [128].
Oxidative stress also appears to play a role in the effects of PM
exposure on circulating endothelial progenitor cells [129]. Indeed,
Haberzettl and colleagues demonstrated that CAPs inhalation in mice
led to a plethora of mechanistic links between endothelial progenitor
cells, vascular insulin resistance, inflammation and oxidative stress,
building on the evidence that air pollution is associated with both
cardiovascular disease and metabolic disease [130]. The same group
demonstrated that nine days inhalation of CAPs depleted circulating
endothelial progenitor cells and led to an impaired angiogenic response
(the growth of new blood vessels) in a mouse model of hind limb
ischaemia [131]. Mice overexpressing extracellular superoxide dis-
mutase in the lung were protected against this effect, suggesting pul-
monary oxidative stress has downstream consequences on the vascu-
lature.
In vitro experiments. Similarly to in vivo studies, isolated blood
vessels directly treated with DEP also exhibit impaired endothelial-de-
pendent vasodilatation and NO-mediated vasodilation, but not relaxa-
tions caused by NO-independent vasodilators [132]. These findings
provide support for the contention that if these particles reach the
systemic circulation (by translocation from the lung into the pulmonary
blood vessels) they could directly impair vascular function through
oxidative stress without the need for prior interaction with the lung or
inflammatory cells [132]. Scavengers of oxygen free radicals and in-
hibitors of enzymatic sources of free radicals can prevent the direct
vascular impairment induced by DEP (see Ref. [7]). Albeit, the direct
effect of PM on endothelial cells may be modest in comparison to that
produced when the particles first interact with inflammatory cells
[133].
Direct exposure of isolated brain capillaries to DEP increased oxi-
dative stress and inflammation; findings that may have implications for
blood brain barrier integrity following inhalation of pollutants [134].
Direct treatment of cultured endothelial cells with PM, DEP or motor-
cycle exhaust particles has also been shown to induce oxidative stress,
alter endothelial cell signalling, upregulate adhesion molecules, down-
regulate endothelial NOS and, ultimately, promote apoptosis
[135–141]. Finally, NAC has been shown to attenuate several effects of
PM (e.g. inflammation and downregulation of NOS) in endothelial cells
[135,136,139,141,142].
4.2. Atherosclerosis
Endothelial dysfunction is an early initiating event in the vascular
disease atherosclerosis. Loss of endothelial function and expression of
adhesion molecules attracts and tethers circulating inflammatory cells
to the vascular wall. Additionally, loss of NO and changes to endothelial
cell phenotype encourage the oxidation of circulating lipids (e.g. low
density lipoprotein (LDL) to oxidized LDL (oxLDL)) that are pre-
ferentially retained by inflammatory cells that begin to penetrate the
damaged endothelial layer. The accumulation of both of inflammatory
cells and lipids induces the formation of a fatty plaque in major arteries
that grow into the lumen to impede blood flow. Erosion or rupture of
advanced plaques is the trigger for thrombosis (a blood clot) that may
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occlude arteries causing a cardiovascular event such as a heart attack or
stroke.
Epidemiology. Individuals with greater exposure to PM (e.g. based
on pollution monitoring data close to residential address, or distance of
the residence from a major road) exhibit greater degrees of athero-
sclerosis, as assessed by a number of methods such as arterial wall
thickness, coronary calcification (a marker of advanced plaques) and
reduction of lumen diameter in the retinal microvasculature (which can
be used as a non-invasive indicator of early atherosclerosis with prog-
nostic value for cardiovascular outcomes) [30,143–146]. Exposure to
ambient PM or BC has been associated with greater levels of in-
flammatory biomarkers and reduced antioxidant activity in the blood of
elderly individuals with coronary artery disease [86]. The narrowing of
retinal blood vessels was associated with PM exposure, paralleled by
increases in circulating levels of micro-RNA implicated with oxidative
stress [147]. Associations have been observed for CIMT and the oxi-
dative capacity of PM10 collected in the year preceding the CIMT
measurements [148].
Occupational exposure to vehicle emissions (e.g. bus drivers and
garagemen) led to greater levels of several markers of systemic oxida-
tive stress in comparison to comparative controls [83,149]. These in-
cluded urinary 8-oxo-2′-deoxyguanosine (8-OH-dG; a marker of oxida-
tive modification of DNA) and 15-isoprostanes, blood levels of protein
carbonyls and nitrotyrosine, and lower levels of antioxidants in plasma.
These observations were correlated to a number of pollutants, including
PM10, PM2.5 and PAHs. There was no striking relationship with blood
levels of LDL or high density lipoprotein (HDL) [83], although the study
did not measure oxLDL specifically. Nonetheless, a similar study found
greater levels of oxLDL and decreased levels of antioxidants in the blood
of taxi drivers [150]. Furthermore, exposure to traffic-related air pol-
lution in Shanghai, China, was associated with elevated levels of LDL.
The effects on LDL were accompanied by increased blood pressure,
indicators of insulin resistance and decreased antioxidant capacity
[151]. An interesting study by Wu et al. recruited students in Beijing
before and after moving to a university campus with higher pollution
levels [152]. Increased exposure to PM2.5, especially PM rich in metals,
led to higher oxLDL in the blood.
The adhesion molecules, vascular cell adhesion molecule-1 (VCAM-
1) and intercellular adhesion molecule-1 (ICAM-1) are involved in the
attraction and tethering of leukocytes to the blood vessel wall, thus
have a role in both early and on-going atherosclerosis. Exposure to
PM2.5 increased levels of soluble VCAM-1 and ICAM-1 in the blood, an
effect that was greater in individuals that are null for glutathione-S-
transferase M1 [153]. Antioxidant-rich fish oils have been shown to
reduce levels of the circulating vasoconstrictor ET-1 that are associated
with PM2.5 exposure [154]. Finally, extracellular vesicles carrying mi-
croRNA represent an emerging mechanism by which the pro-oxidative
and pro-atherosclerotic effect of PM could be disseminated around the
body [155].
Controlled exposures in humans. The acute nature of controlled
exposure studies in human subjects does not lend itself to studying the
chronic development of atherosclerosis. However, it should be borne in
mind that controlled exposure studies have been shown to have acute
cardiovascular effects that will promote the development of vascular
disease (see other sections of this review). Two controlled exposure
studies were identified that specifically implicate oxidative stress in the
atherosclerotic effects of air pollution. Controlled exposure of healthy
subjects to DE increased plasma-soluble lectin-like oxidized low density
lipoprotein receptor (LOX-1) levels, which would be expected to med-
iate, at least in part, the accumulation of lipids within the vascular wall
[156]. High density lipoprotein (HDL) acts to inhibit the oxidation of
LDL, thus having a preventative action on the development of athero-
sclerosis. Controlled exposure to PM2.5, but not ozone, was shown to
reduce the antioxidant activity of HDL in individuals with lower base-
line HDL activity [157].
Animal and in vitro models. Due to the long-term development of
atherosclerosis in humans (over decades) and limited means to non-
invasively measure atherosclerosis clinically, the availability of rodent
models of atherosclerosis has been a boon for studying the mechanisms
underlying atherosclerosis. The apolipoliprotein-E knockout and LDL
Fig. 3. Different histochemical approaches to assess constituents of atherosclerotic plaques. Left panel: Plaques in the brachiocephalic artery of ApoE knockout mice
instilled with diesel exhaust particles or control (saline) [161]. a) Cavities from lipids and cholesterol crystals, b) macrophage-derived foam cells (brown stain), c)
collagen (red), d) smooth muscle cells (brown), e & f) buried fibrous layers (arrows). Right panel: Plaques in the aortic root of ApoE knockout mice inhaling diesel
exhaust or control (filtered air). Data from Bai et al. 2011 [170]. A-C) Inducible nitric oxide synthase expression (pink/red), D-F) CD-3 expressing cells (cells derived
from inflammatory cells; pink/red), G-I) nitrotyrosine staining as a marker of oxidative stress (pink/red).
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receptor knockout mice have been especially useful in this regard, as
advanced atherosclerotic plaques can develop in these mice in a few
weeks if they are fed a high-cholesterol diet. A number of studies have
now shown that exposure to PM or vehicle exhaust particles accelerate
the development of atherosclerosis in these mice, both in terms of in-
creasing plaque size and promoting plaque vulnerability to rupture
(reviewed in Refs. [7,120]). Oxidative stress has been implicated as a
key mechanism for the pro-atherosclerotic effects of pollutants.
PM and DE has been shown to oxidise LDL in vitro [158] and in vivo
[159]. Furthermore, DEP exhibited synergistic effects with lipids on
gene expression in cultured endothelial cells; an effect that was re-
plicated by inhalation of ambient ultrafine PM in hypercholester-
olaemic mice [160]. PM-exposed atherosclerotic mice exhibited bio-
markers of systemic oxidative stress in blood and urine, as well as
alterations in antioxidant systems [43,127,160–166]. Inhalation of ve-
hicle exhaust increased levels of LOX-1 [156,167] and dysfunctional
HDL [164,168]. The antioxidant and inflammatory pathways, nuclear
factor erythroid-2 (Nrf-2) and aryl hydrocarbon receptor (AhR), played
an interacting role in the atherosclerotic effects of air pollution [169].
Furthermore, the plaques from PM-exposed mice have greater levels of
markers of oxidative stress, demonstrated, for example, by nitrotyrosine
staining [170] (Fig. 3). Eight weeks inhalation of PM increased the
thickness of coronary arteries in healthy rats, accompanied by upre-
gulation of angiotensin pathways and decreases in hemogenase-1 levels
[171]. The role of gaseous versus particulate components of vehicle
exhaust may have different effects on markers of oxidative stress and
plaque composition [172,173].
No research was found investigating the ability of antioxidant
compounds to prevent the pro-atherosclerotic effects of pollutants.
However, the antioxidant properties of selenium supplementation, was
found to reduce both oxidative stress and VCAM-1 levels in healthy rats
exposed to PM, which would be expected to influence the early stages of
atherosclerosis [174].
4.3. Arrhythmia and heart rate variability
Heart rate variability (HRV) is a set of parameters derived from
detailed analysis of heart rhythm from electrocardiogram (ECG) re-
cordings. These parameters are indicative of the modulation of the
electrical activity of the heart, in particular, its regulation by the au-
tonomic nervous system. For most HRV parameters, a reduction is
would confer a greater risk of developing cardiovascular conditions (at
a population level). The availability of low-cost non-invasive monitors
to assess HRV has been readily employed to address the cardiac effects
of air pollution, increasingly so in panel studies simultaneously mea-
suring personal air pollution in real-time.
Epidemiology. Although there is inconsistency between parameters
and studies, overall, exposure to PM is associated with reduction in
HRV (see Refs. [62,175]). In students in Taipei, Taiwan, both PM10 and
PM2.5 were associated with decreases in several HRV parameters, as
well as increases in blood 8-OH-dG and C-reactive protein [80]. Per-
sonal monitoring devices were also used to show associations between
PM2.5 and HRV indices in Boston, USA, the effects of which were linked
to urinary levels of 8-OH-dG [176]. A series of US studies by Schwartz
and colleagues demonstrated associations between PM2.5/traffic ex-
posure and several HRV parameters [177–181]. In many cases, altera-
tions in HRV associated with PM2.5 were modified by genetic differ-
ences in antioxidant systems. Similar genetic susceptibility in
antioxidant genes influenced associations between PM2.5 and corrected
Q-T interval [95,182]. In the interests of balance, others have failed to
demonstrate clear links between air pollutants, HRV and oxidative
biomarkers [96,183].
Two groups have explored HRV during interventions to reduce ex-
posure to air pollutants. Langrish et al. demonstrated that wearing an
efficient facemask beneficially altered selected HRV parameters in pa-
tients with ischaemic heart disease walking alongside city-centre roads
in Beijing, in comparison to performing the same walk without a mask
[184]. Laboratory analysis showed that the Beijing PM had a sub-
stantial capacity to generate superoxide free radicals. Also in Beijing,
Lee and colleagues made measurements of HRV in residents during the
2008 Olympic Games when stringent measures were taken to reduce air
pollution [185]. While reduction of air pollution was shown to reduce
levels of urinary markers of oxidative stress, HRV changes were in-
conclusive. The lack of clarity, however, could be explained by pollu-
tant-specific effects as, while PM was reduced considerably, there were
higher levels of ozone during this time. Dietary antioxidant supple-
mentation, omega-3 fish oils in particular, was shown to limit the ef-
fects of air pollution on HRV in elderly individuals [186]. Reductions in
oxidative stress were also partially to account for the beneficial effects
of statins in preventing the effects of PM2.5 on high-frequency HRV
parameters [177,187].
Controlled exposures in humans. A role for oxidative stress in the
action of PM on HRV has been supported by controlled exposure stu-
dies. Acute exposure to ultrafine CAPs altered HRV and cardiac re-
polarization in patients with metabolic syndrome who were null for the
glutathione S-transferase M1 allele, but not a comparative group from
the general population [188]. Controlled exposure to street air in Co-
penhagen was associated with reductions in HRV, although there were
no consistent changes in various oxidative biomarkers [189]. In con-
trast, Tong et al. found that exposure to CAPs reduced HRV in healthy
volunteers, and this could be prevented by 4 weeks of oral omega-3
fatty acid supplements [187].
Animal models. Several studies have addressed the cardiac effects
of pollutants in rodents, demonstrating that PM can alter HRV via au-
tonomic imbalance and alterations in baroreceptor sensitivity [190].
Additionally, infusion of isoprenaline (isoproterenol) was used to pro-
mote arrhythmias, in rodent models [191–193]. Five hours inhalation
of CAPs in rats led to changes in ECG that were accompanied by in-
crease in oxidative stress in cardiac tissue [194] (although it should be
noted that the assays used - chemiluminescence, thiobarbituric acid
reactive substances – can also be increased by alteration in inter-
mediary metabolism rather than oxidative stress). These effects could
be prevented by inhibition of the renin-angiotensin system or pul-
monary sensory receptors. The complex interplay between the oxida-
tive stress and the autonomic system is highlighted by a study that
demonstrated HRV changes to urban PM can be prevented by NAC,
while the cardiac oxidative stress induced by the PM can be inhibited
by blockade of the autonomic nervous system with beta-blockers [195].
Pulmonary instillation of DEP to rats, prior to coronary artery ligation,
increased the incidence of cardiac arrhythmia and the extent of myo-
cardial infarction to the ischaemia induced by ligation [196]. In this
model, DEP-induced ischaemia induced greater levels of superoxide
radical generation in the perfused heart. PM2.5 exposure to rats also
induced changes in HRV and increased cardiac malondialdehyde, the
effects of which were modified by co-exposure to ozone [197]. Lastly,
the prolongation of cardiac action potential and arrhythmias induced
by pulmonary exposure to DEP were prevented by NAC [198].
4.4. Myocardial ischaemia and infarction
Atherosclerosis of the coronary vasculature is the basis for
ischaemic heart disease, where the restriction of blood flow leads to
regions of cardiac ischemic that can manifest as angina. Occlusion of
major coronary arteries can lead to prolonged ischaemia, resulting in
death of the downstream myocardial cells resulting in myocardial in-
farction; fibrosis or death of regions of the heart leading to loss of
cardiac function and obstruction to cardiac electrical conductance.
Epidemiology. Exposure to traffic has been shown to increase the
incidence of acute myocardial infarction in the subsequent hours
[36–38]. Additionally, hospital presentations/admissions for myo-
cardial infarction were greater for those dwelling in areas of high air
pollution [45,48,49]. Long-term exacerbation of atherosclerosis and
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rupture of plaques will make a substantial contribution to the associa-
tions between myocardial infarction and exposure to air pollution.
However, it is likely that many different cardiovascular effects of air
pollution will act in concert to increase the susceptibility to cardio-
vascular events [199].
Oxidative stress (raised levels of blood malondiadehyde) was found
in patients with acute coronary events linked to black carbon exposure
[200]. Pekkanen et al. measured S-T segment depression (a region of an
electrocardiogram representative of ischaemic stress in coronary ar-
teries) in patients with stable coronary artery disease while exercising
in the city of Helsinki, Finland [201]. NO2, CO, PM2.5, particle number
(used as a surrogate for ultrafine PM), but not coarse PM, were asso-
ciated with an increased prevalence of S-T segment depression, with a
lag of 2 days. The associations were stronger in those not taking beta-
blockers, indicating that these effects may be more reflective of auto-
nomic regulation of the heart rather than the coronary arteries, al-
though oxidative stress was not specifically investigated as a me-
chanism in this study. Susceptibility to coronary events (cardiac
mortality, non-fatal myocardial infarction, admission for unstable an-
gina) has also been associated with black carbon exposure (used as a
proxy for combustion-derived particles), with greater levels of mal-
ondialdehyde on admission to hospital [200]. Furthermore, the oxida-
tive potential of PM2.5 (and, to some degree, ozone co-exposure) related
to the risk of myocardial infarction [202]: particulates with the greatest
oxidative potential were associated with ~8% increase in hospital ad-
missions. NO2 exposure has been found to be associated with increased
risk of acute myocardial infarction [203]. The risk varied with poly-
morphisms of genes involved in glutathione pathways, although the
investigators were not able to identify statistically significant changes
in precise genes.
Controlled exposures in humans. The greater sensitivity of the
heart to ischaemic stress was demonstrated using controlled exposures
to diesel exhaust. A 2 h exposure to 300 μg/m3 DE in patients with
ischemic heart caused a two-fold increase in the extent of S-T segment
depression induced in an exercise test [204] (Fig. 4). This observation
built on other work from this group showing that acute exposure to DE
impaired vascular function through oxidative mechanisms [107].
Animal models. Ligation of coronary arteries in rodents can be
used to induce myocardial infarction to address the mechanisms re-
sponsible. Rats instilled with DEP prior to ligation were more prone to
the resultant arrhythmia and likelihood of sudden death [196]. Isola-
tion of the heart afterward showed that the area of infarction was more
than twice as large in rats exposed to DE than those that were non-
exposed. Perfusion of the coronary blood vessel with a superoxide-
sensitive spin-trap reagent demonstrated that there was an increase in
free radical formation in the injured hearts of DE exposed mice. The
antioxidant vanillic acid reduced the effects of PM10 on cardiac anti-
oxidant levels, and partially improved mitochondrial disturbances after
ischaemia reperfusion injury [205]. Similarly, selenium supplementa-
tion decreased the oxidative action of PM2.5 in cardiac tissue in rats
[174]. Interestingly, 4 weeks inhalation of DE in healthy rats led to a
broadly similar profile of cardiac gene expression (one linked with
mitochondrial-derived oxidative stress) in healthy rats to that of air-
exposed spontaneously hypertensive rats, suggesting DE induced si-
milar cardiac changes to hypertension [206]. Gaseous pollutants can
also exert similar effects, with a 1–2 month exposure to ozone in-
creasing ischaemia-reperfusion injury in rats that was characterised by
increases in cardiac lipid peroxidation and decreased SOD activity
[207]. CO exacerbated myocardial injury and depletion of antioxidants
in the heart of a rat model of myocardial infarction [208]. The CO levels
used were at the upper ranges of ambient levels in heavily polluted
urban cities (30 ppm), spiked with peaks representative of that very
close proximity to vehicle exhaust (100 ppm).
In vitro experiments. Direct addition of DEP to cultured cardio-
myocytes reduced contractile function, an effect that could be partially
prevented by antioxidants [209]. Similarly, PM2.5 that was known to
reduce antioxidant capacity in mice, also caused decreased contractility
of cardiomyocytes on direct exposure [210]. Finally, the direct cyto-
toxicity or apoptotic effect of various PM in cardiomyocytes could be
inhibited by compounds with antioxidant properties (e.g. NAC or die-
methylthiourea, a scavenger of hydroxyl radicals and hydrogen per-
oxide) [198,211]. It should be noted that, due to the reaction kinetics of
free radicals with antioxidants in comparison to that of other target
molecules, the physiological relevance of the use of antioxidants as free
radical scavengers in in vitro assays has been questioned [212].
4.5. Cardiac remodelling and heart failure
Heart failure is the term used to describe the loss of the capacity of
the heart as a result of long-term stress from coronary artery disease,
prolonged high blood pressure, increased sympathetic drive, severe
alterations in heart rhythm and damage to the heart from myocardial
Fig. 4. Acute exposure to dilute diesel exhaust exacerbates cardiac ischaemic
stress in patients with ischaemic heart disease. Volunteers were asked to inhale
diesel exhaust (300 μg/m3 for 1 h) during an exercise test. Ischaemic stress was
measured as the extent of S-T segment depression in the ECG. Data from Mills
et al. 2007 [204].
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ischaemia, infarction or congenital defects and viral damage. It is
characterised, ultimately, by a substantial loss of cardiac function so
that the heart cannot deliver blood to meet the needs of the body.
Hypertrophy (a remodelling and thickening of the cardiac wall) is
common, whereby the heart attempts to compensate for the burden it is
placed under, usually leading to a reduction in the efficiency of cardiac
contractility and further pressure on the coronary arteries.
Epidemiology. Exposure to air pollution has been associated with
an increased incidence of heart failure [48]. A meta-analysis [52] of
global data found that a number of air pollutants (PM10, PM2.5, SO2,
NO2, CO, but not O3) were associated with an increase in relative risk
for heart failure. PM2.5was associated with a 2.12% increase in risk per
10 μg/m3, and showed the greater persistence in terms of lag effect - the
only pollutant to be associated with a significant effect 2 days later
(longer lags were not investigated). Left ventricular mass (i.e. hyper-
trophy) was been found to be greater in those residing closer to major
roads [213,214]. These effects were magnified in those with poly-
morphisms for genes linked to inflammation and oxidative stress.
Lastly, oxidative capacity of PM2.5 (via the dithiothreitol assay) showed
stronger associations with hospital admissions for heart failure than
PM2.5 (mass) alone [215] (although it should be noted the dithiothreitol
assay is imprecise and has generated conflicting results elsewhere
[216]).
Animal models. PM2.5 exposure is associated with loss of cardiac
contractility and increased collagen deposition in healthy rats [217].
This study also demonstrated that the same exposure in rats with
myocardial infarction produced a compensatory increase in glutathione
in the cardiac tissue. PM2.5 induced pulmonary inflammation and oxi-
dative stress alongside right ventricular hypertrophy in a mouse model
of heart failure [218]. An impressively intricate study by Wold et al.
investigated the long-term effects of PM in a mouse model of heart
failure, and cultured cardiomyocytes [210]. Nine months exposure to
PM2.5 (moderate levels of CAPs: ~80 μg/m3) led to an increase in blood
pressure of 10 mmHg that was linked to a decreased ventricular con-
tractility and remodelling, without an overall change in coronary flow
reserve. Cardiomyocytes transitioned towards a fibrotic phenotype ra-
ther than contractile (Fig. 5), and these effects were paralleled by a
decrease in plasma total antioxidant capacity. Although the value of the
plasma total antioxidant capacity assay is debated, these observations
could suggest that oxidative stress was involved in the processes of
myocyte transition. PM2.5 exacerbated the effects of angiotensin-in-
duced hypertension, leading to cardiac hypertrophy [219]. These ef-
fects were mediated by RhoA/Rho-kinase signalling pathways, which
the same group had previously shown to be involved in the hyperten-
sive effects of PM2.5 via oxidative mechanisms [123]. Wang et al. found
that inhalation of PM2.5 induced left-ventricular dysfunction in mice. In
this experiment, AMP-activated protein kinase (a protein involved in
the sensing and regulation of cellular metabolism) was implicated in
both the pro-fibrotic response and generation of oxidative stress [220].
Left ventricular function has also been shown to be modified by 1–2
months ozone exposure; effects that were associated with lipid perox-
idation in the heart, decreases in SOD activity and increases in cyto-
kines [221].
4.6. Thombosis
Blood clotting is needed to prevent excessive bleeding on injury.
However, coagulation needs to be finely regulated, as excessive clotting
increases the risk of cardiovascular conditions caused by thrombotic
occlusion of arteries, e.g. at sites of atherosclerotic plaque rupture/
erosion or through lodging of emboli (blood-borne thrombus) in smaller
downstream arteries.
Epidemiology. Thrombotic occlusion of arteries is the predominant
cause of heart attacks and strokes. Several epidemiological studies have
shown that air pollution, and especially PM exposure, is linked to
atherothrombosis, thrombotic stroke and thromboembolism [61]. A
Fig. 5. Nine months inhalation of PM in mice impairs cardiac contractility and promotes cardiac remodelling that is characteristic of heart failure. In cardiomyocytes
PM exposure led to: a) reduction in contraction (PS: peak shortening), b) reduction in cell nucleus:cytoplasm ratio, c) increased expression of transforming growth
factor (TGFB), d) increased protein expression of collagen and decreased SERCA-2 (a Ca2+-ATPase), e) reduction in plasma antioxidant capacity. Data from Wold
et al. 2012 [210].
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plethora of blood markers of pro-thrombotic pathways have been linked
to PM exposure, including fibrinogen, tissue factor, von Willebrand
factor (vWF), P-selectin and decreases in activity of fibrinolytic path-
ways the mediate clot breakdown [61,87,222] (Fig. 6). Associations
between several air pollutants and P-selectin have been shown to be
accompanied by decreases in antioxidant levels in red blood cells [87].
In students in Taipei, Taiwan, both PM10 and PM2.5 increased in blood
8-OH-dG, alongside increases in fibrinogen, C-reactive protein and the
fibrinolytic inhibitor, plasminogen activator inhibitor-1 [80]. In con-
trast, personal measurement of PM2.5 in Copenhagen, Denmark, was
associated with greater levels of oxidation of haemoglobin and plasma
lipids, although there was no correlation between PM2.5 and blood fi-
brinogen levels [85]. Also, while the use of various assays of oxidative
potential of PM was found to have value for predicting pulmonary in-
flammation, there was only limited value in predicting biomarkers of
coagulation [223].
The composition of PM from five locations in the Netherlands has
been explored in relation to thrombotic biomarkers [224]. While PM
composition did have an influence on biomarker levels, there was a less
consistent relationship with the oxidative potential of the PM. A review
of human studies concluded that the metallic components of PM are
involved in its propensity to induce pro-thrombotic and oxidative bio-
markers [225]. Polyunsaturated fatty acids from fish oil have been
shown to reduce blood fibrinogen associated with exposure to PM2.5
[154].
Controlled exposures in humans. Controlled inhalation of dilute
DE in healthy volunteers increased blood coagulability in an ex vivo
model of thrombosis to a damaged arterial wall in physiologically re-
presentative conditions [226]. Activation of platelets and platelet-
monocyte binding were proposed as the driving mechanism for the
increased coagulability, however, the authors speculate a role for oxi-
dative stress and inflammation in the activation of platelets and vas-
cular dysfunction observed in a parallel study with showing increased
thrombosis to DE [116]. A separate group of researchers demonstrated
that DE alters the expression of several antioxidant pathways in per-
ipheral blood monocytes, supporting a role for systemic oxidative stress
in the cardiovascular actions of DE [111]. Another gene profiling study
found that inhalation of DE was associated with changes in pathways of
both coagulation and oxidative stress/inflammation, including Nrf-2
pathways and inducible forms of NOS [227]. Additionally, controlled
exposures to CAPs increased blood plasminogen and markers of acute
phase response in individuals with genetic deficiencies in various an-
tioxidant systems [188]. In contrast, a study of young healthy in-
dividuals asked to spend 5-h at locations with varying PM levels did not
find an association between vWF and the in vitro oxidative potential of
the different PM [152].
Animal models. Pulmonary exposure to PM and DE have also been
shown to upregulate vWF and tissue factor, and downregulate fi-
brinolytic pathways, in rodent models [167]. These changes were as-
sociated with alterations in haemoxygenase-1 and LOX-1 pathways.
Pulmonary instillation of urban PM [228] or DEP [229] has been shown
to accelerate thrombosis at sites of large vessel injury. In contrast,
Nemmar and colleagues found an increase in tail bleeding time (po-
tentially indicating a decrease in thrombogenecity) following pul-
monary instillation of DEP [230]. The authors speculate that this could
be due to decreases in circulating platelet numbers in response to DEP.
Nonetheless, a follow-up study found that DEP instillation increased
thrombosis in cerebral arterioles after photochemical injury [231]. The
changes were accompanied by reduction in antioxidant activity
[230,231], and could be reversed by compounds with antioxidant
properties [231–233]. The pro-thrombotic effect of DEP in arterioles of
a diabetic mouse model were linked to a combined action of increased
platelet activation, decreased fibrinolytic activity, systemic inflamma-
tion and oxidative stress [234]. Lastly, redox-active transition metals in
PM from Mexico City were linked to prothrombotic and anti-fibrinolytic
effects in the rat lung [235]. The surface chemistry of the insoluble
particulate, rather than the aqueous soluble compounds that can leach
from the PM, played a greater contribution to these effects.
In vitro experiments. Direct addition of PM to whole blood has
been used to test to the pro-thrombotic potential of particles. The
concentrations used in these experiments are likely to be beyond that
expected to reach the circulation after inhalation in the real world
[236]. Nonetheless, broad insights into the relative potencies of dif-
ferent PM and potential mechanisms may be garnered. Soluble extracts
of oil-fly ash containing PM were able to directly promote thrombosis,
the extent of which was dependent on metal content of the PM [237].
These effects could be reduced by complexing iron, suggesting that
Fenton-derived hydroxyl free radicals could be a potential mechanism.
A similar observation has been shown for a US urban PM standard re-
ference material [238]. Free-radical generating capacity of PM was
linked to the prothrombotic phenotype of endothelial cells in an in vitro
model of endothelial-fibrin-clot binding [239]. Direct administration of
DEP increased blood coagulation in vitro, which could be prevented
with the antioxidant/anti-inflammatory agent, emodin [231]. Treat-
ment of cultured endothelial cells with ultrafine PM from Chapel Hill,
USA, promoted the ability of these cells to generate active thrombin
from a substrate, an effect that was reversed by SOD and catalase, or
diphenyleneiodonium (a flavoprotein inhibitor that may act through
inhibition of NAD(P)H-oxidase) [240].
Fig. 6. Schematic showing the pathways by which inhalation of pollutants can
promote thrombosis increasing the risk of cardiovascular mortality. Oxidative
stress may represent a key early pathway that instigates other downstream
mechanisms for the pro-thrombotic effect of inhaled pollutants. Additionally,
oxidative and inflammatory mediators are likely to interact with these other
mechanisms at different stages of their pathways (indicated by dotted lines).
Adapted from Robertson & Miller 2018 [222]. Although oxidative stress is
specifically indicated as a mechanism in the first pathway, it may play a con-
tributing role in the mechanisms by which the other four pathways exert their
actions, and through exacerbation of the resultant cardiovascular pathophy-
siology these pathways induce.
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4.7. Stroke
Stroke is caused by ischaemia in the brain that results in sensor-
imotor impairments and potentially damage to the brain or dementia.
Stroke can be categorised by the cause of the ischaemia; ischaemic
stroke caused by atherothrombotic occlusion with the arteries within
the brain or those leading to the brain (e.g. the carotid arteries), or
haemorrhagic stroke caused by rupture of the cerebral blood vessels
and bleeding out into the brain. In either case, ischaemia triggers a
cascade of pathophysiological changes in the cells of the affected area,
and oxidative stress is a key feature of both the ischaemia and damage
caused by sudden reperfusion of the tissues should it occur.
Epidemiology. There is a wealth of epidemiological evidence
showing the exposure to air pollution is associated with increased
hospital admission for stroke in different regions of the world
[56,57,241]. Associations for PM tend to be more consistent than those
for gaseous co-pollutants [54] (Fig. 7) and are observed at levels of air
pollution below many guideline levels [242]. However, the role of
oxidative stress in these associations has received little attention in
epidemiological studies. Although direct evidence is lacking, it has been
postulated that free radical generation from PM promotes stroke
through increased inflammation and blood coagulability [243], which
accords with the stronger associations between air pollution and
ischaemic stroke rather than haemorrhagic stroke [241,242]. While not
necessarily stroke per se, a Swiss study investigated air pollution and
oxidative stress in blood samples from non-smoking patients collected
within 17 years prior to their diagnosis with cerebrovascular disease
[244]. In this study, PM2.5 and NO2 were all associated with methyla-
tion of genes linked to oxidative stress and inflammation.
Animal models. While it is challenging to fully reproduce the
causes and consequences of stroke, in vivo and in vitro models have
provided evidence to suggest that air pollution would exacerbate
stroke, with oxidative stress being an anticipated mechanism [56].
Roadside ultrafine PM, with a known ability to generate free radicals in
vitro, was shown to alter glutamate signalling and cytokine release in
the brain following inhalation in rats [245]. Upregulation of
Fig. 7. Air pollution exposure is associated with stroke. a) Meta-analysis of the epidemiological evidence that exposure to air pollutants is associated with increase
risk of stroke, globally. While the magnitude of the effects for gaseous pollutants can be substantial in some studies, the associations between PM and stroke are more
consistent than gaseous co-pollutants. Data from Shah et al. 2015 [54]. b) Thrombotic occlusion of cerebral pial venules in mice following photochemical injury. Top
panel: accumulation of fluorescein associated with platelets (arrows) to the vessel wall A) prior to injury, B) at time of cessation of blood flow, c) 24-h hours after
injury. Middle panel: pulmonary administration of diesel exhaust particles (DEP) decreases the time to occlusion, i.e. accelerates the clotting of blood. Lower panel:
DEP decreased total equivalent antioxidant capacity (TEAC) in the same mice potentially indicating a role of oxidative stress. Data from Nemmar et al. 2009 [232].
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haemoxygenase expression was observed in the brain after instillation
of PM10 in mice [246]. The effects of PM on the brain have been as-
sociated with levels of transition metals in PM, potentially suggesting a
role for metal-derived free radical generation [247,248]. Oil-combus-
tion PM was shown to cause marginally greater changes in oxidative
stress markers in the lungs and heart of stroke-prone hypertensive rats,
in comparison to either healthy or hypertensive rats that are not prone
to stroke [249]. Oxidative stress was proposed to play a contributing
role in disruption of the blood brain barrier after inhalation of vehicle
exhausts [134,250,251]. Indeed, photochemical induction of throm-
bosis in cerebral microvessels was exacerbated by pulmonary exposure
to DEP; an effect that could be prevented by co-administration of an
antioxidant cysteine pro-drug [232].
In vitro experiments. Cells within the central nervous system are
considered to have a lower reserve of antioxidants in comparison to
many other cell types [252]. Cultured neuronal cells and microglial (the
macrophage-like cell of the nervous system) have been used to show
that PM can induce oxidative stress and cytotoxicity [56]. Free radical
generation from roadside PM regulated N-methyl-D-aspartate (NMDA)
channels (implicated in hypoxic neuronal damage) in cultured neuronal
and glial cells [245]. Similar observations have been found for the di-
rect action of DEP on dopamine signalling in PC-12 cells (used as a
model for neural differentiation) [253]. Additionally, periods of
ischaemia can be induced in cultured brain slices leading to molecular
changes that have representative features of the response to cerebral
ischaemic in vivo. Application of these tissue preparations with various
types of PM can induce cellular-molecular changes characteristic of the
response to stroke (e.g. alterations in NMDA channel activity, dopa-
minergic and glutamatergic disruption). In many cases, such effects are
associated with inflammation and oxidative stress (see Ref. [56]).
Primary cultures of microvascular cells can be used to model cere-
bral arteries. Generation of reactive oxygen species are a prominent
mechanism by which DEP can impair the function of endothelial cells
that line the inner surface of such arteries [160,254]. These cells re-
present a potential early target in the disease processes underlying
cerebrovascular disease. Direct exposure of DEP to isolated brain ca-
pillaries increased oxidative stress and inflammation, and may alter
blood brain barrier permeability [134]. While there is debate as to
whether inhaled particles can access the brain in sufficient numbers,
and penetrate throughout cerebral tissue, these in vitro findings offer a
means by which inhalation of (the smallest ultrafine) particles could
confer increased susceptibility to the consequences of a stroke.
Fig. 8. Contribution of oxidative stress to the mechanisms by which inhaled PM induces cardiovascular dysfunction. A complex series of interconnecting mechanisms
underlies the effects of inhaled PM on cardiovascular morbidity and mortality. O2-. is used to represent places where oxidative stress is likely to play a direct role in
exacerbating the disease process. While a direct action of oxidative stress is not always immediately apparent, it is worth noting that oxidative stress has been
associated with most of the cardiovascular impairments shown on the diagram, and may indirectly contribute to other pathways by which PM has cardiovascular
actions. Abbreviations: BBB = blood brain barrier; ET-1 = endothelin-1; HRV= heart rate variability; NO= nitric oxide; TF = tissue factor; vWF= von Willebrand
Factor.
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5. Conclusions
Awareness of health effects of air pollution is increasing globally,
and has now become a priority issue on the environmental, health and
political agenda. This awareness has been bolstered by global data re-
vealing the staggering magnitude of the health effects of pollution;
culminating in annual mortality rates in excess of several million
people. Additionally, over the last three decades, a formidable body of
scientific evidence on the underlying biology has grown to support a
case for causality in the health effects of air pollution. A crucial sti-
mulus for action has been the wider recognition that the effects of air
pollution are not confined to the lung, but instead have effects in what
appears to be every organ of the body. The cardiovascular effects of
pollution are increasingly gaining mainstream recognition. Given the
high incidence of cardiovascular disease worldwide, and the high
mortality rates that accompany it, the effects of pollution on the car-
diovascular system will remain of key importance. Furthermore, now
there is robust human evidence that inhaled nanoparticles may enter
the bloodstream [23], the circulation is not only a means to deliver
translocated particles throughout the body, but also the direct action of
pollutants on the cardiovascular function could contribute to the effects
of air pollution on different organs of the body (e.g. through hy-
pertension, impaired perfusion of organs, alterations in vascular
growth, etc.) [5].
Substantial progress has been made in determining the biological
mechanisms for the cardiovascular effects of air pollution. A host of
interacting mechanisms has been revealed, however, oxidative stress
represents a key mechanism for the pathophysiological actions of pol-
lution on the different facets of the cardiovascular system (Fig. 8). It is
notable that oxidative stress emerges as a mechanism in the cardio-
vascular actions of pollutants using different research approaches;
across epidemiological studies, controlled exposures in man, animal
models and in vitro preparations. Clearly there are inconsistencies in
evidence and, even before publication bias, studies will inevitably fa-
vour positive results over negative findings (and it should be ac-
knowledged that this is also true to a degree in the present review too).
Nonetheless, the sheer scale of the high-quality research, with com-
plementary findings across multiple endpoints and study types, would
argue that oxidative stress is a crucial mechanism underlying the link
between air pollution and cardiovascular disease. Whether or not oxi-
dative stress is the key initiating event, or only a contributing factor, is
challenging to address, however, its presence will undoubtedly ex-
acerbate disease. The close interplay between oxidative stress and in-
flammation represents a likely means by which the actions of air pol-
lution can be amplified to produce pathophysiological effects in
multiple organs. Furthermore, given the clear pro-oxidative effects of
many pollutants, and capacity for oxidative stress to impair multiple
aspects of cardiovascular function, oxidative stress is likely to play a
key mediating role, as opposed to simply being an epiphenomenon of
the later stages of disease.
Reducing of the sources of pollution should be the key strategy to
alleviate the burden of air pollution on health. However, given the
challenges faced in lowering anthropogenic pollution in the face of
increasing urbanisation, and the inevitably sluggish progress in im-
plementing political and lifestyle changes, there is a place for inter-
ventions that can protect against pollution in the intervening time.
Medicines should not be a first-line strategy to prevent the effects of
pollution, however, this does not mean that such interventions should
be dismissed entirely, especially for those that may be at greater risk
(e.g. the young, elderly, those with pre-existing cardiorespiratory dis-
ease, and those that have an unavoidable high exposure to pollutants).
The consistency of the evidence for a role of oxidative stress in the
actions of air pollution raises the potential for the use of antioxidant
compounds to ameliorate the actions of exposure to pollutants. This is
especially the case given that dietary changes can be a simple means to
increase antioxidant intake. While vitamin supplements have largely
fallen out of favour given the disappointing large-scale trials with car-
diovascular endpoints, it should not be forgotten that these supple-
ments are readily-available, low cost and largely innocuous, and there
is substantial scientific evidence supporting their potential to lessen
aspects of disease. Indeed, this review highlights several preclinical
studies [7,8,255] (see also work by Nemmar et al. e.g. Ref. [256]), as
well as a few small panel studies [257–259] whereby antioxidants can
prevent the cardiovascular effects of air pollution. Of note, a recent
study of over half a million subjects in the USA demonstrated that a
Mediterranean diet rich in antioxidants (higher proportion of fruit and
vegetables, olive oil, oily fish and moderate consumption of alcohol
(e.g. antioxidant-rich red wine)) led to a reduction in the rates of car-
diovascular mortality (from ischaemic heart disease, cardiac arrest and
stroke) associated with PM2.5 and NO2 exposure [259]. Polyunsaturated
fatty acids from fish oil have also been shown to increase antioxidant
enzyme levels and decrease peroxidised lipid/lipoproteins in the blood
[154,187,260,261], as well as ameliorate the effects of PM2.5 on HRV
[186,187], blood fibrinogen, plasma inflammatory markers and en-
dothelin-1 [154]. Similar positive effects of fish oils have been found for
endothelial dysfunction caused by controlled exposure to PM2.5 [114].
Further large scale studies in human volunteers are needed to ascertain
if this approach has merit as an adjunct to strategies to reduce pollu-
tants.
In conclusion, oxidative stress is a key mechanism by which ex-
posure to air pollution causes cardiovascular morbidity and mortality.
Strategies that reduce air pollutants would be expected to reduce the
burden of cardiovascular disease, and potentially other associated
health conditions driven by oxidative pathways.
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